[go: up one dir, main page]

DK107100C - Fremgangsmåde til fremstilling af fluorsubstituerede 7-nitro-1,4-benzodiazepinforbindelser eller syreadditionssalte deraf. - Google Patents

Fremgangsmåde til fremstilling af fluorsubstituerede 7-nitro-1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.

Info

Publication number
DK107100C
DK107100C DK111363A DK111363A DK107100C DK 107100 C DK107100 C DK 107100C DK 111363 A DK111363 A DK 111363A DK 111363 A DK111363 A DK 111363A DK 107100 C DK107100 C DK 107100C
Authority
DK
Denmark
Prior art keywords
fluorosubstituted
nitro
preparation
acid addition
addition salts
Prior art date
Application number
DK111363A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK107100C publication Critical patent/DK107100C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/28Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK111363A 1962-03-21 1963-03-11 Fremgangsmåde til fremstilling af fluorsubstituerede 7-nitro-1,4-benzodiazepinforbindelser eller syreadditionssalte deraf. DK107100C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18144062A 1962-03-21 1962-03-21

Publications (1)

Publication Number Publication Date
DK107100C true DK107100C (da) 1967-04-24

Family

ID=22664289

Family Applications (1)

Application Number Title Priority Date Filing Date
DK111363A DK107100C (da) 1962-03-21 1963-03-11 Fremgangsmåde til fremstilling af fluorsubstituerede 7-nitro-1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.

Country Status (7)

Country Link
BR (1) BR6347165D0 (da)
CH (3) CH454888A (da)
DE (1) DE1445872A1 (da)
DK (1) DK107100C (da)
ES (1) ES286241A1 (da)
GB (1) GB1039372A (da)
SE (1) SE312808B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529203A1 (fr) * 1982-06-24 1983-12-30 Fabre Sa Pierre Procede industriel d'obtention et de purification de flunitrazepam de qualite pharmaceutique

Also Published As

Publication number Publication date
BR6347165D0 (pt) 1973-07-19
GB1039372A (en) 1966-08-17
SE312808B (da) 1969-07-28
CH454888A (de) 1968-04-30
ES286241A1 (es) 1963-11-16
DE1445872A1 (de) 1969-04-10
CH441342A (de) 1967-08-15
CH455814A (de) 1968-05-15

Similar Documents

Publication Publication Date Title
DK107029C (da) Fremgangsmåde til fremstilling af substituerede 2-arylamino-1,3-diazacycloalkener eller syreadditionssalte deraf.
DK108497C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner eller syreadditionssalte deraf.
DK107024C (da) Fremgangsmåde til fremstilling af 4-amino-6,7-dialkoxykinoliner eller syreadditionssalte deraf.
DK115999B (da) Fremgangsmåde til fremstilling af 9,10-dihydro-ergovalin eller syreadditionssalte heraf.
DK109037C (da) Fremgangsmåde til fremstilling af 2-alkyl-3-hydroxy-4,5-di-hydroxymethyl-pyridiner eller syreadditionssalte deraf.
DK114840B (da) Fremgangsmåde til fremstilling af diaralkylaminer eller syreadditionssalte heraf.
DK109779C (da) Fremgangsmåde til fremstilling af 3-aminopyrazinamidoguanidinforbindelser eller syreadditionssalte heraf.
DK121123B (da) Fremgangsmåde til fremstilling af 1,2-dihydro-4-phenyl-quinazolin-3-oxider eller syradditionssalte deraf.
DK111894B (da) Fremgangsmåde til fremstilling af diphenylalkylaminer eller syreadditionssalte deraf.
DK115110B (da) Fremgangsmåde til fremstilling af anticholeterolemeisk sktive 25-aza-19-nor-1,3,5(10)-cholestatriener eller syreadditionssalte deraf.
DK127507B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK118657B (da) Analogifremgangsmåde til fremstilling af 3',4',5'-trimethoxy-3-aminoacrylophenoner eller syreadditionssalte deraf.
DK107100C (da) Fremgangsmåde til fremstilling af fluorsubstituerede 7-nitro-1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK114828B (da) Fremgangsmåde til fremstilling af 5-hydroxy-5-aminoalkyl-10,11-dihydro-5H-dibenzo-(a,d)-cykloheptener eller syreadditionssalte deraf.
DK104408C (da) Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK120600B (da) Fremgangsmåde til fremstilling af 5-aryl-1,4-benzodiazepin-2-oner eller syreadditionssalte deraf.
DK116288B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-1,4-benzodiazepiner eller syreadditionssalte deraf.
DK113993B (da) Fremgangsmåde til fremstilling af 3-alkylsulfonyl-5-hydroxy-5-(3-tertiær-aminopropyl)-5H-dibenzo-[a,d]-cycloheptener eller syreadditionssalte deraf.
DK112449B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepiner eller syreadditionssalte deraf.
DK105472C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK109676C (da) Fremgangsmåde til fremstilling af primære alkylphenylalkylaminer eller syreadditionssalte deraf.
DK106093C (da) Fremgangsmåde til fremstilling af 2-pyrrolidino-1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK118667B (da) Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-5-phenyl-2H-1,4-benzodiazepin-2-oner eller syreadditionssalte deraf.
DK108726C (da) Fremgangsmåde til fremstilling af 1,3-dihydro-5-pyridyl-7-trifluormethyl-2H-1,4-benzodiazepin-2-oner eller syreadditionssalte deraf.
DK113651B (da) Fremgangsmåde til fremstilling af 6,11-dihydro-11-(3-alkylaminopropyl)-dibenzo-[b,e]thiepiner eller syreadditionssalte deraf.